International Vaccine Institute strategic demand forecasting; and Sabin – communications and advocacy. Besides leading the consortium, IVI generated evidence for decision-making such as disease burden, country vaccine introduction cases and a global investment case. From 2010 to 2016, DVI operated in Brazil, Burkina Faso, Cambodia, Colombia, Gabon, India, Kenya, Thailand, and Vietnam. From 2013-2015, with funding from Germany’s Federal Ministry of Education & Research (BMBF), IVI continued support for preclinical development of dengue vaccines by Brazil’s Butantan Institute and Vietnam’s VaBiotech. After the 2016 licensure of Sanofi Pasteur’s Dengvaxia vaccine, the DVI project came to a close and its IVI staff transitioned to
South African Institute of Tax Practitioners Board elected by members. When SAIT was formed in 2007 by its main founder Stiaan Klue, the Institute announced that one member of the Board may be nominated by the South African Revenue Service (SARS). SARS said they agreed in principle with the general objectives of SAIT. In 2014 SAICA joined SAIT and other SARS recognised controlling bodies to host the Tax Indaba - SAIT is the founder of the Tax Indaba in South Africa. Other organisations representing tax professionals in the country are the South African Institute of Chartered Accountants (SAICA) and the South African Institute of Professional Accountants